At Infused Health, we provide biologic therapies that address the root causes of severe asthma and chronic airway inflammation—not just the symptoms. These treatments are ideal for patients who continue to experience flare-ups despite inhalers or steroids, especially those with eosinophilic asthma or allergic asthma.

​

We partner closely with pulmonologists, allergists, and primary care providers to ensure seamless, supportive care.

​

Current Therapies Offered

• CINQAIR®—An anti–IL-5 monoclonal antibody used for severe eosinophilic asthma

• FASENRA®—For severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis (EGPA)

• NUCALA®—Approved for severe eosinophilic asthma, EGPA, hypereosinophilic syndrome (HES), and chronic rhinosinusitis with nasal polyps (CRSwNP)

• TEZSPIRE®—For severe asthma, regardless of eosinophil level or allergic status. Targets TSLP (thymic stromal lymphopoietin), a key driver of airway inflammation

• XOLAIR®—Used for moderate to severe allergic asthma, chronic rhinosinusitis with nasal polyps, chronic spontaneous urticaria, and food allergies

​

Providers: Click on any medication name below to download the referral form.